{"code":"E16.3","type":"code","title":"Increased secretion of glucagon","codeAlso":[],"includes":[],"modern_v":"official26","codeFirst":[],"excludes1":[],"excludes2":[],"isBillable":true,"sibling_codes":["E16","E16.0","E16.1","E16.2","E16.4","E16.8","E16.9","E16.A","E16.A1","E16.A2","E16.A3"],"inclusionTerms":["Hyperplasia of pancreatic endocrine cells with glucagon excess"],"sibling_titles":{"code":"E16.A3","title":"Hypoglycemia level 3","isBillable":true},"useAdditionalCode":[],"clinicalDefinition":"Increased secretion of glucagon is a billable ICD-10-CM diagnosis code (E16.3). Inclusion terms: Hyperplasia of pancreatic endocrine cells with glucagon excess.","officialDefinition":"Increased secretion of glucagon is a billable ICD-10-CM diagnosis code (E16.3). Inclusion terms: Hyperplasia of pancreatic endocrine cells with glucagon excess.","seventhCharacterInstructions":[],"workflowProtocols":[],"guidelines":{"whenToUse":[],"whenNotToUse":[],"commonBillingMistakes":[],"codeComparisons":[],"documentationChecklist":[]},"domainLandscape":{"summary":"Primary diagnostic domain and clinical landscape evaluation.","keyCategories":[],"diagnosticContinuum":"Progression continuum from acute presentation to resolution."},"children":[],"hierarchy":[],"relatedCodes":[],"relevantCPTCodes":[],"documentationTips":[],"caseStudies":[],"description":"","overview":""}